P
Prajnan Das
Researcher at University of Texas MD Anderson Cancer Center
Publications - 317
Citations - 12590
Prajnan Das is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 45, co-authored 276 publications receiving 9801 citations. Previous affiliations of Prajnan Das include University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Quality Assessment in Oncology
Jeffrey M. Albert,Prajnan Das +1 more
TL;DR: The aims of the present report were to review the current state of quality assessment in oncology, identify existing indicators with the best evidence to support their implementation, and propose a framework for identifying and refining measures most indicative of true quality in onCologic care.
Journal ArticleDOI
Intensity-Modulated Radiation Therapy With Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma
Twisha Chakravarty,Christopher H. Crane,Jaffer A. Ajani,Paul F. Mansfield,Tina Marie Briere,A. Sam Beddar,Henry Mok,Valerie Klairisa Reed,Sunil Krishnan,Marc E. Delclos,Prajnan Das +10 more
TL;DR: Preoperative IMRT for gastric adenocarcinoma was well tolerated, accomplished excellent target coverage and normal structure sparing, and led to appropriate pathologic outcomes.
Journal ArticleDOI
Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases.
Sunil Krishnan,Edward H. Lin,G. Brandon Gunn,A. Chandra,A. Sam Beddar,Tina Marie Briere,Prajnan Das,Marc E. Delclos,Nora A. Janjan,Christopher H. Crane +9 more
TL;DR: Conformal RT to the dominant liver metastasis as palliative therapy for unresectable colorectal cancer liver metastases has an acceptable toxicity profile and may improve survival.
Journal ArticleDOI
Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex with Men
Ashish A. Deshmukh,Jagpreet Chhatwal,Elizabeth Y. Chiao,Alan G. Nyitray,Prajnan Das,Scott B. Cantor +5 more
TL;DR: Vinating HIV-positive MSM aged ≥27 years with qHPV vaccine after treatment for HGAIN is a cost-saving strategy and expansion of current vaccination guidelines to include this population should be a high priority.
Journal ArticleDOI
Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy
Naruhiko Ikoma,Mariela A. Blum,Jeannelyn S. Estrella,Prajnan Das,Wayne L. Hofstetter,Keith Fournier,Paul F. Mansfield,Jaffer A. Ajani,Brian D. Badgwell +8 more
TL;DR: The AJCC 8th edition staging system for gastric cancer demonstrated reasonable survival prediction by ypStage, but not cStage, in patients who had undergone preoperative therapy and potentially curative gastrectomy.